BSH 2018 | The burden of VTE in cancer patients: impacts and novel treatments
Venous thromboembolism (VTE) effects 20% of all cancer patients. In this interview with Cihan Ay, MD, from the Medical University of Vienna, Vienna, Austria, discusses the occurrence and implications of VTE in cancer patients compared to those without cancer. The discussion covers identification techniques, management strategies and novel therapies for VTE. This video was recorded the British Society for Haematology (BSH) 2018 Annual Scientific Meeting, held in Liverpool, UK.
Get great new content delivered to your inboxSign up